BEIT Inc.

BEIT Inc. is a Canadian computational drug discovery company. According to its official website, it provides an integrated computational pipeline for small-molecule drug discovery, spanning target and pocket preparation, virtual screening, higher-fidelity rescoring, and scalable free energy perturbation (FEP). The company positions itself around applying "the right level of physics at the right stage" — fast screening where scale matters, higher-fidelity scoring where confidence matters, and FEP where medicinal chemistry decisions need deeper evidence. The BEIT workflow is organized into five stages: Prepare, Screen, Rescore, Optimize, and Extend. Stage 01 (Prepare) covers target and pocket preparation, binding-mode hypotheses, and screening-ready structures. Stage 02 (Screen) uses high-throughput docking and virtual screening to prioritize hits at scale. Stage 03 (Rescore) re-ranks shortlists with higher-fidelity physics to reduce false positives and focus synthesis and assay budgets. Stage 04 (Optimize) applies scalable FEP for congeneric series and medicinal chemistry cycles. The pipeline is described as HPC- and GPU-enabled and scientist-led. BEIT markets itself to small-molecule teams and offers a scientific discovery call as an entry point, suggesting a service or platform engagement model rather than a pure software product. Its website lists docking, rescoring, FEP, and covalent capabilities. The company's stated focus is on helping teams make better molecule decisions through physics-based modeling. Beyond the information published on its website and its Wikidata entry describing it as a Canadian drug discovery company, few public details are available about BEIT's founding, leadership, ownership, or funding. The dossier below reflects only what can be supported by the supplied evidence.

Publicly available information about BEIT Inc.'s corporate history is limited. The company is described in its Wikidata entry as a Canadian drug discovery company, and its official website presents it as a provider of computational drug discovery services for small-molecule teams. The website describes an integrated pipeline organized into five stages — Prepare, Screen, Rescore, Optimize, and Extend — covering target and pocket preparation, high-throughput docking and virtual screening, higher-fidelity rescoring, scalable FEP, and covalent modeling. The site emphasizes a philosophy of applying the right level of physics at the right stage: fast screening where scale matters, higher-fidelity scoring where confidence matters, and FEP where medicinal chemistry decisions need deeper evidence. The pipeline is described as HPC- and GPU-enabled and scientist-led. No founding date, founder names, funding events, or ownership details are provided in the available evidence.

Physics-based modeling for better molecule decisions; applying the right level of physics at the right stage for small-molecule teams.

• Prepare stage

  Target and pocket preparation, binding-mode hypotheses, and screening-ready structures.

• Screen stage

  High-throughput docking and virtual screening to identify promising candidates faster.

• Rescore stage

  Re-rank shortlists with higher-fidelity physics to reduce false positives.

• Optimize stage

  Scalable FEP for congeneric series and medicinal chemistry cycles.

• Extend stage

  Further pipeline extension (details not specified in evidence).

1. 1BEIT — Physics-based modeling for molecule decisionsbeit.tech
2. 2BEIT Inc. — Wikidatawikidata.org